Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated balance sheets

v3.22.1
Consolidated balance sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 128,879 $ 23,943
Short-term investments 0 30,000
Restricted deposits 11,474 1,454
Accounts receivable, net 31,017 25,257
Deferred contract costs 8,470 5,495
Prepaid expenses and other current assets 7,847 2,096
Total current assets 187,687 88,245
Property and equipment, net 6,356 6,090
Deferred contract costs, noncurrent 9,208 6,030
Intangible assets, net 11,617 0
Goodwill 11,318 2,868
Other non-current assets 813 401
Total assets 226,999 103,634
Current liabilities:    
Borrowings under Credit Facility 0 26,853
Accounts payable 11,303 4,349
Payroll and benefit related liabilities 17,969 11,022
Deferred revenue 76,676 53,145
Total other payables and accrued expenses 28,199 12,987
Total current liabilities 134,147 108,356
Deferred revenue, non-current 2,074 743
Deferred rent 2,602 3,012
Other long-term liabilities 3,262 773
Total liabilities 142,085 112,884
Commitments and contingencies (Note 16)
Convertible Preferred Shares, NIS 0.01 par value 51,877,220 and 0 shares authorized as of December 31, 2020 and 2021, respectively; 50,657,042, and 0 shares issued and outstanding as of December 31, 2020, and 2021, respectively; 0 135,810
Shareholders' (deficit) equity    
Ordinary Shares, NIS 0.01 par value 79,176,826 and 500,000,000 shares authorized as of December 31, 2020 and 2021, respectively; 15,328,449 and 74,847,609 shares issued as of December 31, 2020, and 2021, respectively; 15,326,281 and 74,845,441 outstanding as of December 31, 2020 and 2021, respectively; 205 42
Additional paid-in capital 324,614 25,908
Accumulated other comprehensive income 160 76
Accumulated deficit (240,065) (171,086)
Total shareholders' (deficit) equity 84,914 (145,060)
Total liabilities, convertible preferred shares and shareholders' (deficit) equity $ 226,999 $ 103,634